Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 May 24;14(6):364.
doi: 10.3390/toxins14060364.

Regulatory Networks Controlling Neurotoxin Synthesis in Clostridium botulinum and Clostridium tetani

Affiliations
Review

Regulatory Networks Controlling Neurotoxin Synthesis in Clostridium botulinum and Clostridium tetani

Michel R Popoff et al. Toxins (Basel). .

Abstract

Clostridium botulinum and Clostridium tetani are Gram-positive, spore-forming, and anaerobic bacteria that produce the most potent neurotoxins, botulinum toxin (BoNT) and tetanus toxin (TeNT), responsible for flaccid and spastic paralysis, respectively. The main habitat of these toxigenic bacteria is the environment (soil, sediments, cadavers, decayed plants, intestinal content of healthy carrier animals). C. botulinum can grow and produce BoNT in food, leading to food-borne botulism, and in some circumstances, C. botulinum can colonize the intestinal tract and induce infant botulism or adult intestinal toxemia botulism. More rarely, C. botulinum colonizes wounds, whereas tetanus is always a result of wound contamination by C. tetani. The synthesis of neurotoxins is strictly regulated by complex regulatory networks. The highest levels of neurotoxins are produced at the end of the exponential growth and in the early stationary growth phase. Both microorganisms, except C. botulinum E, share an alternative sigma factor, BotR and TetR, respectively, the genes of which are located upstream of the neurotoxin genes. These factors are essential for neurotoxin gene expression. C. botulinum and C. tetani share also a two-component system (TCS) that negatively regulates neurotoxin synthesis, but each microorganism uses additional distinct sets of TCSs. Neurotoxin synthesis is interlocked with the general metabolism, and CodY, a master regulator of metabolism in Gram-positive bacteria, is involved in both clostridial species. The environmental and nutritional factors controlling neurotoxin synthesis are still poorly understood. The transition from amino acid to peptide metabolism seems to be an important factor. Moreover, a small non-coding RNA in C. tetani, and quorum-sensing systems in C. botulinum and possibly in C. tetani, also control toxin synthesis. However, both species use also distinct regulatory pathways; this reflects the adaptation of C. botulinum and C. tetani to different ecological niches.

Keywords: Clostridium botulinum; Clostridium tetani; botulinum neurotoxin; small RNA; tetanus neurotoxin; toxin gene regulation; two-component system.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Genetic organization of neurotoxin genes in representative Clostridium botulinum and Clostridium tetani strains. red, neurotoxin genes; orange, ntnh genes; purple, regulatory genes; green, ha genes; cyan, orfX and p47 genes.
Figure 2
Figure 2
Two-component systems (TCSs) involved in neurotoxin gene regulation in Clostridium botulinum strain Hall and ATCC3502 and in Clostridium tetani strain E88.
Figure 3
Figure 3
Schematic representation of the regulatory pathways in Clostridium botulinum and Clostridium tetani. TCS, two-component system; AIP, autoinducing peptide. External factors act through TCSs and/or other unknown receptors or transporters (blue arrows).

References

    1. Dong M., Masuyer G., Stenmark P. Botulinum and Tetanus Neurotoxins. Annu. Rev. Biochem. 2019;88:811–837. doi: 10.1146/annurev-biochem-013118-111654. - DOI - PMC - PubMed
    1. Pirazzini M., Montecucco C., Rossetto O. Toxicology and pharmacology of botulinum and tetanus neurotoxins: An update. Arch. Toxicol. 2022;96:1521–1539. doi: 10.1007/s00204-022-03271-9. - DOI - PMC - PubMed
    1. Dover N., Barash J.R., Hill K.K., Xie G., Arnon S.S. Molecular characterization of a novel botulinum neurotoxin type H gene. J. Infect. Dis. 2014;209:192–202. doi: 10.1093/infdis/jit450. - DOI - PubMed
    1. Zhang S., Masuyer G., Zhang J., Shen Y., Lundin D., Henriksson L., Miyashita S.I., Martinez-Carranza M., Dong M., Stenmark P. Identification and characterization of a novel botulinum neurotoxin. Nat. Commun. 2017;8:14130. doi: 10.1038/ncomms14130. - DOI - PMC - PubMed
    1. Peck M.W., Smith T.J., Anniballi F., Austin J.W., Bano L., Bradshaw M., Cuervo P., Cheng L.W., Derman Y., Dorner B.G., et al. Historical Perspectives and Guidelines for Botulinum Neurotoxin Subtype Nomenclature. Toxins. 2017;9:38. doi: 10.3390/toxins9010038. - DOI - PMC - PubMed